US · Healthcare

ZyVersa Therapeutics Inc. (ZVSA)

Biotechnology

ZyVersa Therapeutics Inc. (ZVSA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ZVSA

P/E ratio

25.00

ZyVersa Therapeutics Inc. (ZVSA) — FAQ

What is ZVSA's P/E ratio?

The price-to-earnings (P/E) ratio for ZyVersa Therapeutics Inc. (ZVSA) is 25.00 (data as of 2026-05-23).

Does ZyVersa Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for ZyVersa Therapeutics Inc. (ZVSA). Check the MyAverix Finance app for the latest dividend data.

What sector is ZyVersa Therapeutics Inc. in?

ZyVersa Therapeutics Inc. (ZVSA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ZVSA listed on?

ZVSA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)